It regulates the NLRP3-mediated inflammatory signaling pathway negatively, inhibits the secretion of proinflammatory mediators and activation of macrophages, reduces the intestinal inflammation level and limits the development of colitis-associated cancers (21). Here, NLRP3 is linked to colitis.